Although most studies indicate that BRCA2 mutations are associated with prolonged survival in invasive epithelial ovarian cancer [30], we presented a case of a patient with BRCA1 mutation and extended survival benefit. This evidence concerns the gene BRCA2 and ovarian carcinoma.